Investigating the Role of ACE۲ Receptors in the Rate of COVID-۱۹ Infectivity in Smokers and Opioid Abusers: A Review

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 14

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JOBJ-11-3_005

تاریخ نمایه سازی: 18 اردیبهشت 1403

Abstract:

It seems necessary to understand the association of severe acute respiratory syndrome coronavirus ۲ (SARS-CoV-۲), which causes coronavirus disease ۲۰۱۹ (COVID-۱۹), with its entering bronchoalveolar and brain cells, which have a high concentration of angiotensin-converting enzyme ۲ (ACE۲). Although the virus infects healthy people, the rate of infection and mortality is higher and significant in vulnerable people, such as drug users and addicts who have acute and chronic respiratory disease. It also places a heavy economic burden on families and societies around the world. Thus, researchers are aiming to provide prevention and treatment strategies to people at risk. The purpose of the present study was to collect studies on the rate of infection with coronavirus in people who abuse drugs. Besides, the role of the ACE۲ receptor as a key factor in coronavirus infectivity in these people was investigated. Our narrative review on the relationship between COVID-۱۹ and opioid abuse and smoking, with consideration of ACE۲'s role, contains original and human studies. According to the results of the current study, those who smoke or are dependent on opioids are much more likely to experience COVID-۱۹-related respiratory side effects or even pass away.

Authors

narges Marefati

Department of Physiology and Medical Physics, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

Hassan Ghoshooni

Department of Medical Microbiology, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

mostafa mahabadi

Department of Medical Microbiology, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Hamed SM, Elkhatib WF, Khairalla AS, Noreddin AM. Global dynamics ...
  • Leung JM, Yang CX, Tam A, Shaipanich T, Hackett T-L, ...
  • Meftahi GH, Jangravi Z, Sahraei H, Bahari Z. The possible ...
  • Cai G, Bossé Y, Xiao F, Kheradmand F, Amos CI. ...
  • Lapperre TS, Postma DS, Gosman MM, Snoeck-Stroband JB, ten Hacken ...
  • Mehta S, Parmar N, Kelleher M, Jolley CJ, White P, ...
  • Vozoris NT, Wang X, Fischer HD, Bell CM, O'Donnell DE, ...
  • Park J-E, Jung S, Kim A. MERS transmission and risk ...
  • Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern ...
  • Chen YH, Wu KL, Tsai MT, Chien WH, Chen ML, ...
  • Vardavas CI, Nikitara K. COVID-۱۹ and smoking: A systematic review ...
  • Althobaiti YS, Alzahrani MA, Alsharif NA, Alrobaie NS, Alsaab HO, ...
  • Kashyap VK, Dhasmana A, Massey A, Kotnala S, Zafar N, ...
  • Lin Z. Mechanisms for substance use disorders in COVID-۱۹. Mol ...
  • Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate ...
  • Mallet J, Dubertret C, Le Strat Y. Addictions in the ...
  • Dubey MJ, Ghosh R, Chatterjee S, Biswas P, Chatterjee S, ...
  • Saeedi M, Omrani-Nava V, Maleki I, Hedayatizadeh-Omran A, Ahmadi A, ...
  • World Health Organization. WHO report on the global tobacco epidemic, ...
  • Elisia I, Lam V, Cho B, Hay M, Li MY, ...
  • Boulet LP, Catherine L, Francine A, Guy C, Descary MC, ...
  • Rennard SI. Cigarette smoke in research. Am J Respir Cell ...
  • KuKanich B, Wiese AJ. Opioids. Vet Anaesth Analg. ۲۰۱۵:۲۰۷-۲۶ ...
  • Lord JA, Waterfield AA, Hughes J, Kosterlitz HW. Endogenous opioid ...
  • Holden JE, Jeong Y, Forrest JM. The endogenous opioid system ...
  • Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ. ...
  • Krajnik M, Schäfer M, Sobański P, Kowalewski J, Bloch-Bogusławska E, ...
  • Tahamtan A, Tavakoli-Yaraki M, Salimi V. Opioids/cannabinoids as a potential ...
  • Cismaru CA, Cismaru GL, Nabavi SF, Ghanei M, Burz CC, ...
  • Becker WC, Fiellin DA. When epidemics collide: coronavirus disease ۲۰۱۹ ...
  • Lambert DG. Opioids and the COVID-۱۹ pandemic: does chronic opioid ...
  • Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-۱۹ risk ...
  • Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, ...
  • Hung Y-H, Hsieh W-Y, Hsieh J-S, Liu C, Tsai C-H, ...
  • Imai Y, Kuba K, Rao S, Huan Y, Guo F, ...
  • Kuba K, Imai Y, Rao S, Gao H, Guo F, ...
  • Rivellese F, Prediletto E. ACE۲ at the centre of COVID-۱۹ ...
  • Dalan R, Bornstein SR, El-Armouche A, Rodionov RN, Markov A, ...
  • Miyara M, Tubach F, Pourcher V, Morelot-Panzini C, Pernet J, ...
  • Schultze A, Walker AJ, MacKenna B, Morton CE, Bhaskaran K, ...
  • Lukassen S, Chua RL, Trefzer T, Kahn NC, Schneider MA, ...
  • Sims AC, Baric RS, Yount B, Burkett SE, Collins PL, ...
  • Osan JK, Talukdar SN, Feldmann F, DeMontigny BA, Jerome K, ...
  • Voinsky I, Gurwitz D. Smoking and COVID‐۱۹: Similar bronchial ACE۲ ...
  • Hao S, Ning K, Kuz CA, Vorhies K, Yan Z, ...
  • Wu C, Zheng M, Yang Y, Gu X, Yang K, ...
  • Matusiak M, Schürch CM. Expression of SARS-CoV-۲ entry receptors in ...
  • Parry AH, Wani AH, Yaseen M. Neurological dysfunction in coronavirus ...
  • Clarke NE, Belyaev ND, Lambert DW, Turner AJ. Epigenetic regulation ...
  • Ferguson D, Koo JW, Feng J, Heller E, Rabkin J, ...
  • Conti-Fine BM, Navaneetham D, Lei S, Maus AD. Neuronal nicotinic ...
  • Wang Y, Pereira E, Maus A, Ostlie N, Navaneetham D, ...
  • Oakes JM, Fuchs RM, Gardner JD, Lazartigues E, Yue X. ...
  • Farsalinos K, Eliopoulos E, Leonidas DD, Papadopoulos GE, Tzartos S, ...
  • Farsalinos K, Niaura R, Le Houezec J, Barbouni A, Tsatsakis ...
  • Sifat AE, Nozohouri S, Villalba H, Vaidya B, Abbruscato TJ. ...
  • Russo P, Bonassi S, Giacconi R, Malavolta M, Tomino C, ...
  • Li G, He X, Zhang L, Ran Q, Wang J, ...
  • Maremanda KP, Sundar IK, Li D, Rahman I. Age-dependent assessment ...
  • Vleeming W, Rambali B, Opperhuizen A. The role of nitric ...
  • Coleman JW. Nitric oxide in immunity and inflammation. Int Immunopharmacol. ...
  • Martel J, Ko Y-F, Young JD, Ojcius DM. Could nasal ...
  • Dias Junior CA, Cau SBdA, Tanus Santos JE. Role of ...
  • Boskabady M, Marefati N, Farkhondeh T, Shakeri F, Farshbaf A, ...
  • Barnes PJ, Shapiro SD, Pauwels R. Chronic obstructive pulmonary disease: ...
  • Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. ...
  • Imai K, Mercer B, Schulman L, Sonett J, D'Armiento J. ...
  • Serota DP, Barocas JA, Springer SA. Infectious complications of addiction: ...
  • Wei Y, Shah R. Substance use disorder in the COVID-۱۹ ...
  • Kienbaum P, Thurauf N, Michel MC, Scherbaum N, Gastpar M, ...
  • Porubsky S, Kuppe C, Maier T, Birk H-W, Wörnle M, ...
  • Gibson A, Randall D, Degenhardt L. The increasing mortality burden ...
  • Kuczeriszka M, Lipkowski AW, Sadowski J, Kompanowska-Jezierska E. An endomorphine ...
  • Dubey MJ, Ghosh R, Chatterjee S, Biswas P, Chatterjee S, ...
  • Dunlop A, Lokuge B, Masters D, Sequeira M, Saul P, ...
  • Adams CD, Altshuler J, Barlow BL, Dixit D, Droege CA, ...
  • Steffens C, Sung M, Bastian LA, Edelman EJ, Brackett A, ...
  • Eisenstein TK. The role of opioid receptors in immune system ...
  • Hussey HH, Katz S. Infections resulting from narcotic addiction: report ...
  • Eisenstein TK, Rahim RT, Feng P, Thingalaya NK, Meissler JJ. ...
  • Kemp HI, Corner E, Colvin LA. Chronic pain after COVID-۱۹: ...
  • Kiserud Y, Rosland JH. Lindring av truende kvelning hos døende ...
  • Schimmel J, Manini AF. Opioid use disorder and COVID-۱۹: biological ...
  • Madera-Salcedo IK, Cruz SL, Gonzalez-Espinosa C. Morphine decreases early peritoneal ...
  • Wang J, Charboneau R, Balasubramanian S, Barke RA, Loh HH, ...
  • Nabati S, Asadikaram G, Arababadi MK, Shahabinejad G, Rezaeian M, ...
  • Menzebach A, Hirsch J, Nöst R, Mogk M, Hempelmann G, ...
  • Wang J, Barke RA, Charboneau R, Loh HH, Roy S. ...
  • Hudzik B, Nowak J, Zubelewicz-Szkodzinska B. Consideration of immunomodulatory actions ...
  • Hsiao P-N, Chang M-C, Cheng W-F, Chen C-A, Lin H-W, ...
  • Liu H-C, Anday JK, House SD, Chang SL. Dual effects ...
  • Ghobadian R, Khaleghzadeh-Ahangar H. Smoke, nicotine, opioids, and cannabinoids effects ...
  • Dolati-Somarin A, Abd-Nikfarjam B. The reasons for higher mortality rate ...
  • Jalodia R, Antoine D, Braniff RG, Dutta RK, Ramakrishnan S, ...
  • Fayazi HS, Naeimi A, Yaseri M, Khatibani SS. The Effect ...
  • نمایش کامل مراجع